Moraxella catarrhalis - An underestimated culprit for community-acquired lower respiratory tract infections in diseased adult lungs
Abstract
In four months, five cases of Moraxella causing lower respiratory tract infection were encountered among patients with underlying lung disease in the Pulmonary medicine outpatient department of a tertiary care center in rural West Bengal. The patients exhibited a spectrum of clinical presentations, ranging from mild to severe respiratory symptoms along with shortness of breath as the most consistent symptom. Diagnostic workup revealed Moraxella catarrhalis as the causative agent of lower respiratory tract infections in all cases, highlighting its emerging role as a significant respiratory pathogen. Treatment strategies varied based on disease severity, but all the patients improved with treatment. These cases underscore the importance of considering Moraxella as a causative organism for community-acquired lower respiratory tract infection and emphasize the need for continued surveillance and research to better understand its epidemiology and clinical management.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.